The final patient completing our pivotal F351 Phase 3 trial marks an important milestone for Gyre and our development pipeline. We are grateful to the patients, researchers, trial investigators, and ...
Gyre Therapeutics, Inc. ("Gyre") (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on ...
Nestled in the northeast of South Africa, Kruger National Park is a vast expanse of untamed wilderness that offers some of the most magical wildlife experiences on the planet. A safari here is not ...